Biorthex and France's Scient'x in implants merger:
This article was originally published in Clinica
Canadian company Biorthex (Montreal) and Scient'x, of France, aim to merge and form a company specialising in spinal implants. The company will target the US market, and ultimately seek to penetrate other world markets. Biorthex will pay cash and shares up to a value of Can$8 million ($5 million) to French company Ideal Medical Products for its Scient'x shares. Biorthex is also planning to raise cash from institutional investors to allow it to expand.